Clinical Trials Directory

Explore 118,444 clinical trials worldwide

Showing 81601-81650 of 118,444 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (118,444)

NCT06351085
Enhancing Lung Cancer Screening Through Human-Centered Intervention
NARecruiting
2,869 participants
Started: Nov 10, 2022 · Completed: Apr 14, 2025
1 condition1 sponsor1 location
NCT05456321
CIFASD 5 tDCS and Cognitive Training
NARecruiting
70 participants
Started: Nov 10, 2022 · Completed: May 31, 2027
1 condition1 sponsor1 location
NCT05754541
Guo's Endovascular Aortic Arch Replacement of Aortic Dissection by WeFlow-Tribranch Endoprothesis: a Multicenter Pilot Study(GRAFT Study)
NARecruiting
20 participants
Started: Nov 10, 2022 · Completed: Dec 31, 2025
1 condition1 sponsor4 locations
NCT05855668
Phenotyping Patients With Alcohol and Cannabis Use Disorders Using the Addictions Neuroclinical Assessment
NARecruiting
400 participants
Started: Nov 10, 2022 · Completed: Dec 31, 2027
2 conditions3 sponsors1 location
NCT06203106
NYSCF Scientific Discovery Biobank
N/ARecruiting
10,000 participants
Started: Nov 10, 2022 · Completed: Nov 10, 2045
29 conditions1 sponsor1 location
NCT05623215
ALknee Follow-up Study of the Cementless ATTUNE Rotating Platform and the Cementless LCS Rotating Platform Knee System
N/AActive, not recruiting
49 participants
Started: Nov 10, 2022 · Completed: May 31, 2029
3 conditions2 sponsors1 location
NCT05756608
Fibrosis in Chronic and Delayed Myocardial Infarction
N/ARecruiting
180 participants
Started: Nov 10, 2022 · Completed: Nov 10, 2025
3 conditions1 sponsor1 location
NCT05580068
Investigation and Validation of a Study Project on Digital Therapy Management of Patients With Arterial Hypertension
NARecruiting
100 participants
Started: Nov 10, 2022 · Completed: Oct 31, 2024
2 conditions1 sponsor1 location
NCT05753176
Online 1-Day CBT-Based Workshops for Preventing Postpartum Depression
NAActive, not recruiting
412 participants
Started: Nov 10, 2022 · Completed: Dec 31, 2025
2 conditions1 sponsor1 location
NCT05078866
Cancer Preventive Vaccine Nous-209 for Lynch Syndrome Patients
PHASE1/PHASE2Active, not recruiting
45 participants
Started: Nov 10, 2022 · Completed: Sep 30, 2026
2 conditions1 sponsor4 locations
NCT05587192
Radical Prostatectomy Without Prostate Biopsy Following PSMA PET/CT Based on Diagnostic Model
NAActive, not recruiting
57 participants
Started: Nov 10, 2022 · Completed: Jun 30, 2024
1 condition1 sponsor1 location
NCT05607758
Digital Stress Management Intervention for Health Care Providers
NAActive, not recruiting
117 participants
Started: Nov 10, 2022 · Completed: Jul 31, 2025
3 conditions1 sponsor1 location
NCT06122454
A Phase Ic/IIb Study to Evaluate the Efficacy,Safety and Pharmacokinetics of HST in Patients With CHB
PHASE1/PHASE2Recruiting
48 participants
Started: Nov 10, 2022 · Completed: Dec 30, 2024
3 conditions2 sponsors1 location
NCT05393791
Phase II Randomised Controlled Trial of Patient-specific Adaptive vs. Continuous Abiraterone or eNZalutamide in mCRPC
PHASE2Recruiting
168 participants
Started: Nov 10, 2022 · Completed: Nov 10, 2027
1 condition3 sponsors19 locations
NCT05488665
The COMPLETE Treatment of Bifurcation With Two-stent Techniques: Randomized Comparison of Crush Versus Culotte Technique
NARecruiting
512 participants
Started: Nov 10, 2022 · Completed: Sep 27, 2028
1 condition1 sponsor1 location
NCT05583227
Efficacy and Safety of Tezepelumab in Patients With Eosinophilic Esophagitis
PHASE3Active, not recruiting
368 participants
Started: Nov 10, 2022 · Completed: Mar 23, 2027
1 condition2 sponsors125 locations
NCT05400616
Nasal Microbiota Transfer Therapy in Chronic Rhinosinusitis Without Nasal Polyps (CRSsNP)
NARecruiting
60 participants
Started: Nov 10, 2022 · Completed: Dec 31, 2025
1 condition4 sponsors3 locations
NCT05124886
Gut Kidney Axis in Enteric Hyperoxaluria
NARecruiting
80 participants
Started: Nov 10, 2022 · Completed: Mar 1, 2026
1 condition2 sponsors1 location
NCT05533112
Binaural Beat Stimulation to Improve Patient Outcome After Surgery and Anesthesia
NARecruiting
120 participants
Started: Nov 10, 2022 · Completed: Oct 31, 2024
2 conditions1 sponsor1 location
NCT05718622
Evaluation and Prediction of the Effect of EECP on HR-NICE Patients
NARecruiting
100 participants
Started: Nov 10, 2022 · Completed: Nov 30, 2027
1 condition1 sponsor1 location
NCT05706454
Phase 2/Phase 3 Study To Evaluate The Efficacy And Safety Of Ramatroban Along With The Standard Of Care In Subjects Hospitalized For COVID Pneumonia
PHASE2/PHASE3Recruiting
324 participants
Started: Nov 10, 2022 · Completed: May 31, 2026
2 conditions7 sponsors7 locations
NCT05092191
Cannabis as a Complementary Treatment in Multiple Sclerosis
PHASE2Recruiting
250 participants
Started: Nov 10, 2022 · Completed: May 10, 2025
1 condition3 sponsors1 location
NCT05625581
Tofatib Treatment for IgG4-related Disease
N/ARecruiting
40 participants
Started: Nov 10, 2022 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT05409664
Moving Forward Together 4
NAActive, not recruiting
68 participants
Started: Nov 10, 2022 · Completed: Jan 31, 2026
2 conditions4 sponsors1 location
NCT05744973
Multi-level Predictors of Structural Racism and Discrimination and Associations With Health and Well-being Across the Life Course in Diverse Families
N/ARecruiting
631 participants
Started: Nov 10, 2022 · Completed: Jan 31, 2028
1 condition2 sponsors2 locations
NCT05745090
N-terminal Pro-B-type Natriuretic Peptide (NT-proBNP) in Type 2 Diabetes Mellitus
N/AActive, not recruiting
1,200 participants
Started: Nov 10, 2022 · Completed: Apr 30, 2029
3 conditions2 sponsors1 location
NCT05623020
A Study to Learn About the Effects of the Combination of Elranatamab (PF-06863135), Daratumumab, Lenalidomide or Elranatamab and Lenalidomide Compared With Daratumumab, Lenalidomide, and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma Who Are Not Candidates for Transplant
PHASE3Recruiting
966 participants
Started: Nov 10, 2022 · Completed: Nov 29, 2031
1 condition1 sponsor73 locations
NCT06277297
Prognotic Role of CMR in Takotsubo Syndrome
N/ARecruiting
350 participants
Started: Nov 9, 2022 · Completed: Nov 30, 2032
3 conditions11 sponsors1 location
NCT05578703
ABLATE WEIGHT (Ablation Plus ESG for Weight Loss)
NAActive, not recruiting
10 participants
Started: Nov 9, 2022 · Completed: Jun 30, 2026
1 condition1 sponsor1 location
NCT05593029
A Trial of the Safety and Efficacy of SEP-363856 in the Treatment of Adults With Major Depressive Disorder
PHASE2Active, not recruiting
900 participants
Started: Nov 9, 2022 · Completed: Nov 14, 2025
1 condition1 sponsor76 locations
NCT05306600
Onco-Genomas Brasil: Mapping Breast and Prostate Cancer in the Brazilian Public Health System
N/ARecruiting
882 participants
Started: Nov 9, 2022 · Completed: Dec 31, 2026
2 conditions2 sponsors19 locations
NCT05358639
Combination of Olaparib and Navitoclax in Women with HGSC and TNBC
PHASE1Active, not recruiting
36 participants
Started: Nov 9, 2022 · Completed: Apr 28, 2025
3 conditions4 sponsors3 locations
NCT05648786
Socializing a Science-Based Digital Therapeutic for Substance Use Disorders
NAActive, not recruiting
189 participants
Started: Nov 9, 2022 · Completed: Dec 31, 2024
2 conditions2 sponsors1 location
NCT05340023
Proteomic Pattern Associated With the Diagnosis of Chronic Thromboembolic Pulmonary Hypertension
N/ARecruiting
120 participants
Started: Nov 9, 2022 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT04589325
Ixekizumab Diabetes Intervention Trial (I-DIT)
PHASE2Recruiting
127 participants
Started: Nov 9, 2022 · Completed: Dec 31, 2027
1 condition1 sponsor17 locations
NCT05595486
Baby2Home (B2H) Mobile Health Application
NAActive, not recruiting
642 participants
Started: Nov 9, 2022 · Completed: Sep 30, 2025
5 conditions3 sponsors2 locations
NCT05616390
Sintilimab Combined With Bevacizumab and Liver Protective Support Therapy in Unresectable Hepatocellular Carcinoma
PHASE2Recruiting
30 participants
Started: Nov 9, 2022 · Completed: Nov 30, 2025
1 condition1 sponsor1 location
NCT05184582
Physical Exercise During Preoperative Chemotherapy for Breast Cancer
NARecruiting
712 participants
Started: Nov 9, 2022 · Completed: Jun 30, 2028
1 condition1 sponsor13 locations
NCT05509933
Budesonide Prophylaxis for Engraftment Syndrome After Hematopoietic Cell Transplantation
PHASE3Recruiting
110 participants
Started: Nov 9, 2022 · Completed: Dec 30, 2026
1 condition1 sponsor1 location
NCT05452031
A Dyadic Sleep Health Approach for Persons With Alzheimer's Disease and Caregivers
NARecruiting
672 participants
Started: Nov 9, 2022 · Completed: Aug 31, 2027
1 condition3 sponsors3 locations
NCT05178966
Evaluation of Efficiency of One Day Patient/Caregiver Psychoeducation on the Caregiver's Burden
NARecruiting
240 participants
Started: Nov 9, 2022 · Completed: Nov 30, 2025
2 conditions1 sponsor1 location
NCT05590689
Radiodynamic Therapy (RDT) With Gliolan in Patients With First Recurrence of Brain Tumor
PHASE1/PHASE2Recruiting
34 participants
Started: Nov 9, 2022 · Completed: Jan 31, 2027
1 condition2 sponsors1 location
NCT05499390
AK112 in Advanced Non-Small Cell Lung Cancer
PHASE3Active, not recruiting
398 participants
Started: Nov 9, 2022 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT05640700
Vaginal Microbiome and HPV Pre-malignant and Cervical Dysplasia
N/ARecruiting
90 participants
Started: Nov 9, 2022 · Completed: Dec 30, 2025
4 conditions1 sponsor1 location
NCT05585151
High-Resolution Assessment of Extracranial Plaques in a Multiple Centers Evolocumab Randomized Study
PHASE4Recruiting
200 participants
Started: Nov 9, 2022 · Completed: Oct 1, 2024
1 condition1 sponsor1 location
NCT05624138
The Possible Protective Role of Ketotifen Against Oxaliplatin Induced Peripheral Neuropathy
PHASE3Recruiting
64 participants
Started: Nov 9, 2022 · Completed: Jun 30, 2025
1 condition1 sponsor1 location
NCT05163119
Randomized Trial on Mobile Technology and Young Drivers' Cellphone Use
NARecruiting
1,200 participants
Started: Nov 9, 2022 · Completed: Jun 30, 2026
2 conditions4 sponsors1 location
NCT05455931
Real World Observational Study of Poteligeo in Adult Patients With MF and SS (PROSPER)
N/AActive, not recruiting
73 participants
Started: Nov 9, 2022 · Completed: Aug 7, 2025
1 condition1 sponsor19 locations
NCT05641987
Effectiveness of the Educator Well-being Program
NAEnrolling by invitation
4,000 participants
Started: Nov 9, 2022 · Completed: Aug 31, 2026
4 conditions2 sponsors1 location
NCT04454476
Reversal of Preneoplastic Metaplasia in the Stomach With MEK Inhibitor
PHASE1Active, not recruiting
15 participants
Started: Nov 9, 2022 · Completed: Dec 31, 2025
4 conditions1 sponsor3 locations